Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3976494 | Brachytherapy | 2015 | 7 Pages |
Abstract
For patients with Stages I-II UCS, adjuvant radiotherapy type did not influence survival after hysterectomy. This study addresses an existing evidence gap and identifies a trend toward increasing utilization of BT alone. Prospective trials are warranted to provide high-quality evidence to guide adjuvant therapy decisions for these patients.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Nirav Patel, Sarah E. Hegarty, Leigh A. Cantrell, Mark V. Mishra, Timothy N. Showalter,